Drug Free Solution, Inc.
Drug Free Solution, Inc. (DSOL) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
dsol · pe ratio · data through May 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Drug Free Solution, Inc. (DSOL) measures how much investors pay for each dollar of the company's trailing earnings. DSOL's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.00.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-05-31
PE Ratio History
2013 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Drug Free Solution, Inc.You DSOL | $0M | N/A | — | -$0.00 |
 Alternate Health Corp. AHGIF | $0M | N/A | — | -$0.44 |
 The Cannabist Company Holdings Inc. CBSTF | $14M | N/A | — | -$0.23 |
 Cynata Therapeutics Limited CYYNF | $37M | N/A | — | -$0.05 |
 iAnthus Capital Holdings, Inc. ITHUF | $32M | N/A | — | -$0.01 |
 Leef Brands Inc. LEEEF | $33M | N/A | — | -$0.10 |
 Medical Developments International Limited MDDVF | $34M | 608.90x | — | $0.00 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-05-31Latest FY2025 | — | $-0.00 | — | |
2024-05-31 FY2024 | — | $-0.00 | — | |
2023-05-31 FY2023 | — | $-0.00 | — | |
2020-05-31 FY2020 | — | $-0.00 | — | |
2019-05-31 FY2019 | — | $-0.01 | — | |
2018-05-31 FY2018 | — | $-0.00 | — | |
2017-05-31 FY2017 | — | $-0.00 | — | |
2013-05-31 FY2013 | — | $-8.93 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Drug Free Solution, Inc. (DSOL) measures how much investors pay for each dollar of the company's trailing earnings. DSOL's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.00.
Frequently asked questions
DSOL pe ratio · 6 questionsDSOL's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.00. Data sourced from Financial Modeling Prep via DSOL's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Drug Free Solution, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09